Hanaki M - Search Results

1

Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids.

Hanaki M, Murakami K, Akagi K, Irie K. Hanaki M, et al. Bioorg Med Chem. 2016 Jan 15;24(2):304-13. doi: 10.1016/j.bmc.2015.12.021. Epub 2015 Dec 12. Bioorg Med Chem. 2016. PMID: 26719209

2

Inhibitory Activities of Antioxidant Flavonoids from Tamarix gallica on Amyloid Aggregation Related to Alzheimer's and Type 2 Diabetes Diseases.

Ben Hmidene A, Hanaki M, Murakami K, Irie K, Isoda H, Shigemori H. Ben Hmidene A, et al. Among authors: hanaki m. Biol Pharm Bull. 2017;40(2):238-241. doi: 10.1248/bpb.b16-00801. Biol Pharm Bull. 2017. PMID: 28154265 Free article.

3

Mechanistic analyses of the suppression of amyloid β42 aggregation by apomorphine.

Hanaki M, Murakami K, Katayama S, Akagi KI, Irie K. Hanaki M, et al. Bioorg Med Chem. 2018 May 1;26(8):1538-1546. doi: 10.1016/j.bmc.2018.01.028. Epub 2018 Feb 2. Bioorg Med Chem. 2018. PMID: 29429575

4

Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomers.

Murakami K , Yoshioka T , Horii S , Hanaki M , Midorikawa S , Taniwaki S , Gunji H , Akagi KI , Kawase T , Hirose K , Irie K . Murakami K , et al. Among authors: hanaki m. Chem Commun (Camb). 2018 Jun 14;54(49):6272-6275. doi: 10.1039/c8cc03230k. Chem Commun (Camb). 2018. PMID: 29850758

5

Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant Neurotoxicity.

Irie Y, Murakami K, Hanaki M, Hanaki Y, Suzuki T, Monobe Y, Takai T, Akagi KI, Kawase T, Hirose K, Irie K. Irie Y, et al. Among authors: hanaki m. ACS Chem Neurosci. 2017 Apr 19;8(4):807-816. doi: 10.1021/acschemneuro.6b00390. Epub 2017 Jan 12. ACS Chem Neurosci. 2017. PMID: 28026168

6

Semisynthesis and Structure-Activity Studies of Uncarinic Acid C Isolated from Uncaria rhynchophylla as a Specific Inhibitor of the Nucleation Phase in Amyloid β42 Aggregation.

Yoshioka T, Murakami K, Ido K, Hanaki M, Yamaguchi K, Midorikawa S, Taniwaki S, Gunji H, Irie K. Yoshioka T, et al. Among authors: hanaki m. J Nat Prod. 2016 Oct 28;79(10):2521-2529. doi: 10.1021/acs.jnatprod.6b00392. Epub 2016 Oct 4. J Nat Prod. 2016. PMID: 27700077

7

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis.

Murakami K, Tokuda M, Suzuki T, Irie Y, Hanaki M, Izuo N, Monobe Y, Akagi K, Ishii R, Tatebe H, Tokuda T, Maeda M, Kume T, Shimizu T, Irie K. Murakami K, et al. Among authors: hanaki m. Sci Rep. 2016 Jul 4;6:29038. doi: 10.1038/srep29038. Sci Rep. 2016. PMID: 27374357 Free PMC article.

8

Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region.

Murakami K, Suzuki T, Hanaki M, Monobe Y, Akagi K, Irie K. Murakami K, et al. Among authors: hanaki m. Biochem Biophys Res Commun. 2015 Oct 23;466(3):463-7. doi: 10.1016/j.bbrc.2015.09.051. Epub 2015 Sep 11. Biochem Biophys Res Commun. 2015. PMID: 26367176

9

Synthesis and biochemical characterization of quasi-stable trimer models of full-length amyloid β40 with a toxic conformation.

Irie Y , Hanaki M , Murakami K , Imamoto T , Furuta T , Kawabata T , Kawase T , Hirose K , Monobe Y , Akagi KI , Yanagita RC , Irie K . Irie Y , et al. Among authors: hanaki m. Chem Commun (Camb). 2018 Dec 20;55(2):182-185. doi: 10.1039/c8cc08618d. Chem Commun (Camb). 2018. PMID: 30519688

10

Enzymatic in situ saccharification of cellulose in aqueous-ionic liquid media.

Kamiya N, Matsushita Y, Hanaki M, Nakashima K, Narita M, Goto M, Takahashi H. Kamiya N, et al. Among authors: hanaki m. Biotechnol Lett. 2008 Jun;30(6):1037-40. doi: 10.1007/s10529-008-9638-0. Epub 2008 Feb 5. Biotechnol Lett. 2008. PMID: 18250967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results